Description: Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the treatment of coronary artery disease; coronary technology products, such as balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty; intraluminal ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides cardiac rhythm management devices consisting of implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; and implantable pacemaker systems, including implantable cardiac resynchronization therapy pacemaker systems to treat heart failure. In addition, the company offers endoscopy products, such as devices to treat diseases of the digestive and pulmonary systems; and peripheral interventions to diagnose and treat peripheral vascular disease. Further, it provides stone management products comprising ureteral stents, wires, lithotripsy devices, stone retrieval devices, sheaths, balloons, and catheters to treat urinary stone disease and benign prostatic hyperplasia; and mid-urethral sling products, sling materials, graft materials, pelvic floor reconstruction kits, and suturing devices for women's health. Additionally, it provides neuromodulation products used for the management of chronic pain; and medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart, such as radio frequency (RF) generators, steerable RF ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. The company was founded in 1979 and is headquartered in Natick, Massachusetts.
Home Page: www.bostonscientific.com
BSX Technical Analysis
300 Boston Scientific Way
Marlborough,
MA
01752-1234
United States
Phone:
508 683 4000
Officers
Name | Title |
---|---|
Mr. Michael F. Mahoney | Chairman, Pres & CEO |
Mr. Daniel J. Brennan | Exec. VP & CFO |
Mr. Joseph M. Fitzgerald | Exec. VP & Group Pres of Cardiology |
Mr. Jeffrey B. Mirviss | Exec. VP & Pres of Peripheral Interventions |
Mr. John Bradley Sorenson | Exec. VP of Global Operations |
Mr. Jonathan R Monson | VP, Global Controller & Chief Accounting Officer |
Ms. Jodi Euerle Eddy | Sr. VP and Chief Information & Digital Officer |
Ms. Susan Vissers Lisa | VP of Investor Relations |
Mr. Vance R. Brown | Sr. VP, Gen. Counsel & Corp. Sec. |
Ms. Catherine Jennings | VP of Global Marketing & New Bus. Devel. of Peripheral Interventions |
Exchange: NYSE
Country: US : United States of America
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 24.2718 |
---|---|
Trailing PE: | 111.1951 |
Price-to-Book MRQ: | 3.8306 |
Price-to-Sales TTM: | 5.2793 |
IPO Date: | 1992-05-18 |
Fiscal Year End: | December |
Full Time Employees: | 41000 |